GregFASTBioMedical-6
Gregory B. Brown, MD

Chief Executive Officer, Memgen, Vice Chairman and Founder of HealthCare Royalty Partners

GregFASTBioMedical-6
Gregory B. Brown, MD

Dr. Brown has more than 40 years’ experience in healthcare and life science investments. He is currently Chief Executive Officer of Memgen, a development-stage biotechnology company. He also serves as the Vice Chairman and Founder of HealthCare Royalty Partners, a healthcare-focused private asset management firm, and has guided fundraising and investment of more than $3 billion in biopharmaceutical and medical products. Dr. Brown previously served as Managing Director of Paul Capital Partners, a U.S. private equity firm with $5 billion under management. Prior to Paul Capital, he was a Managing Director and Co-Head of Investment Banking at Adams, Harkness & Hill, and Vice President of Corporate Finance at Vector Securities International.
JimFASTBioMedical-7
Jim Dillon

President & CEO, BioVentrix

JimFASTBioMedical-7
Jim Dillon

Mr. Dillon is the President & CEO of BioVentrix, an innovative company focused on improving treatment for heart failure. He started at St. Jude Medical in 2011 and has held a series of increasingly responsible corporate strategic and sales leadership positions. Within these roles, he drove market development and new technology adoption, executed capital/consumable sales strategies and built high performance elite commercial teams focused on the sales and marketing of complex and innovative medical devices. Dillon was also involved with multiple highly successful medical device companies including startups VNUS Medical Technologies, Perclose, Heart Technologies, and Devices for Vascular Intervention as a key contributor to their acquisition and exit, as well as providing prominent leadership related to both sales and business development. Prior to joining St. Jude, he also held senior executive sales and marketing positions with such companies as Abiomed, TherOx and InfraReDx, where he was intimately involved with global clinical development and commercial distribution.

PhilFASTBioMedical-3
Phil Lodato

General Counsel and Chief Compliance Officer, Elevate Ventures

PhilFASTBioMedical-3
Phil Lodato

Phil Lodato serves as General Counsel and Chief Compliance Officer at Elevate Ventures, one of the most active venture capital firms in the Great Lakes region. In this role, he has closed over 300 investment transactions. Before his time at Elevate, Phil served as Legal Counsel to the Indiana 21st Century Research and Technology Fund (a program of the Indiana Economic Development Corporation), in addition to multiple roles in private practice as a corporate and securities attorney.
FredFASTBioMedical-5
Fred McClure

Former Head of IT Quality, Roche Diagnostics

FredFASTBioMedical-5
Fred McClure

Mr. McClure has over 2 decades of global experience in the Pharmaceutical and Medical Device industries.  He has served in leadership roles in the areas of Quality, Regulatory, Clinical Trials and Information Technology.  In these roles, Mr. McClure has supported successful regulatory clearances and approvals necessary to effectively launch new technologies and products.  He has also developed global teams to implement these new technologies and products.

Mr. McClure is currently the President of F&M Investment Office, LLC.  F&M is an entrepreneurial-focused Single Family Office with over $50 million in investments across a diverse group of industries including biotechnology, information technology, real estate and hospitality. In his role as President, he leverages his industry experience, operational savvy and financial acumen to lead F&M's portfolio of investments. In addition to managing all investments, he holds seats on a number of Boards representing F&M where he provides oversight, input and direction in the areas of clinical trials, quality, regulatory and organizational management. Mr. McClure is also the President of the Arthur Dean Family Foundation - a private foundation established by the McClure family that is committed to providing central Indiana youth with opportunities that will lead to their development, well-being and long-term ability to thrive.

JoeFASTBioMedical-6
Joe Muldoon

CEO, FAST BioMedical

JoeFASTBioMedical-6
Joe Muldoon

Joe Muldoon leverages 30 years of experience, from technology start-up organizations to publicly traded multinational companies. He has worked with many high-growth entrepreneurial companies, occasionally serving as Angel Investor and CEO. Joe has advised select medical technology companies, including TGX Medical, Vasc-Alert, Trust Bearer Labs, and Geist Pharmaceuticals. Previously, he was President and CEO of FirstMile Technologies, a start-up broadband provider he led through its sale. Prior to that, he served as President of Brightpoint North America, a publicly traded Fortune 500 wireless company that grew to $750MM under his leadership. He has also held executive general management positions at MacMillan. Joe has a Bachelor of Science in Business from Indiana University’s Kelley School of Business.
BruceFASTBioMedical-6
Bruce Molitoris, MD, FASN

Medical Director/Founder, FAST BioMedical

BruceFASTBioMedical-6
Bruce Molitoris, MD, FASN

Dr. Molitoris is Professor of Medicine and served as director of the Nephrology Division at the Indiana University School of Medicine for 18 years. He is President of the American Society of Nephrology and Director of the Indiana Center for Biological Microscopy. He is funded by the National Institute of Health (NIH), Veterans Administration, and industry. As a leader in the areas of Acute Renal Failure (ARF) and microscopic imaging he has over $1.5 million in direct funding annually. He is also on several editorial boards and NIH review panels.

News & Announcements